Business Description
ExpreS2ion Biotech Holding AB
ISIN : SE0008348262
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 37.02 | |||||
Equity-to-Asset | 0.79 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | -0.02 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -0.37 | |||||
Beneish M-Score | -2.99 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -43.6 | |||||
3-Year EBITDA Growth Rate | -48.1 | |||||
3-Year EPS without NRI Growth Rate | -41.6 | |||||
3-Year FCF Growth Rate | -45.6 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 67.98 | |||||
9-Day RSI | 63.23 | |||||
14-Day RSI | 58.19 | |||||
6-1 Month Momentum % | 141.94 | |||||
12-1 Month Momentum % | -51.15 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5 | |||||
Quick Ratio | 5 | |||||
Cash Ratio | 4.04 | |||||
Days Sales Outstanding | 60.97 | |||||
Days Payable | 697.56 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -34.3 | |||||
Shareholder Yield % | -54.04 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 35.64 | |||||
Operating Margin % | -2002.75 | |||||
Net Margin % | -1832.85 | |||||
FCF Margin % | -1844.81 | |||||
ROE % | -123.63 | |||||
ROA % | -100.75 | |||||
ROIC % | -616.09 | |||||
ROC (Joel Greenblatt) % | -4814.17 | |||||
ROCE % | -131.38 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 16.79 | |||||
PB Ratio | 1.75 | |||||
Price-to-Tangible-Book | 1.8 | |||||
EV-to-EBIT | -0.47 | |||||
EV-to-Forward-EBIT | -0.97 | |||||
EV-to-EBITDA | -0.47 | |||||
EV-to-Forward-EBITDA | -0.97 | |||||
EV-to-Revenue | 9.35 | |||||
EV-to-Forward-Revenue | 5.36 | |||||
EV-to-FCF | -0.29 | |||||
Price-to-Net-Current-Asset-Value | 1.9 | |||||
Price-to-Net-Cash | 2.52 | |||||
Earnings Yield (Greenblatt) % | -214.48 | |||||
FCF Yield % | -91.22 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
ExpreS2ion Biotech Holding AB Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | 6.913 | ||
EPS (TTM) (kr) | -2.97 | ||
Beta | 0 | ||
Volatility % | 147.55 | ||
14-Day RSI | 58.19 | ||
14-Day ATR (kr) | 0.28029 | ||
20-Day SMA (kr) | 2.38075 | ||
12-1 Month Momentum % | -51.15 | ||
52-Week Range (kr) | 0.713 - 5.97 | ||
Shares Outstanding (Mil) | 51.4 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
ExpreS2ion Biotech Holding AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
ExpreS2ion Biotech Holding AB Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
ExpreS2ion Biotech Holding AB Frequently Asked Questions
What is ExpreS2ion Biotech Holding AB(OSTO:EXPRS2)'s stock price today?
When is next earnings date of ExpreS2ion Biotech Holding AB(OSTO:EXPRS2)?
Does ExpreS2ion Biotech Holding AB(OSTO:EXPRS2) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |